Large-scale testing (Phase 3)Study completedNCT00996606
What this trial is testing
Tocilizumab in Combination With Disease-Modifying Anti-Rheumatic Drugs (DMARDs) in Participants With Moderate to Severe Active Rheumatoid Arthritis With an Inadequate Response to DMARDs
Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 58